Comprehensive exploratory autoantibody profiling in patients with early rheumatoid arthritis treated with methotrexate or tocilizumab

por Teitsma, Xavier M., Devenport, Jenny, Jacobs, Johannes W. G., Pethö-Schramm, Attila, Borm, Michelle E. A., Budde, Petra, Bijlsma, Johannes W. J., Lafeber, Floris P. J. G.
Publicado 2020

Identification of differential co-expressed gene networks in early rheumatoid arthritis achieving sustained drug-free remission after treatment with a tocilizumab-based or methotre...

por Teitsma, Xavier M., Jacobs, Johannes W. G., Mokry, Michal, Borm, Michelle E. A., Pethö-Schramm, Attila, van Laar, Jacob M., Bijlsma, Johannes W. J., Lafeber, Floris P. J.
Publicado 2017

Efficacy of Tocilizumab Monotherapy Versus Tocilizumab and Methotrexate Combination Therapy in the Prevention of Radiographic Progression in Rheumatoid Arthritis: An Analysis Using...

por Verhoeven, Maxime M. A., Tekstra, Janneke, Jacobs, Johannes W. G., Bijlsma, Johannes W. J., van Laar, Jacob M., Pethö‐Schramm, Attila, Borm, Michelle E. A., Lafeber, Floris P. J., Welsing, Paco M. J.
Publicado 2022

Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combin...

por Teitsma, Xavier M, Yang, Wei, Jacobs, Johannes W G, Pethö-Schramm, Attila, Borm, Michelle E A, Harms, Amy C, Hankemeier, Thomas, van Laar, Jacob M, Bijlsma, Johannes W J, Lafeber, Floris P J G
Publicado 2018

Effectiveness and safety over 3 years after the 2-year U-Act-Early trial of the strategies initiating tocilizumab and/or methotrexate

por Verhoeven, Maxime M A, Tekstra, Janneke, Welsing, Paco M J, Pethö-Schramm, Attila, Borm, Michelle E A, Bruyn, George A W, Bos, Reinhard, Griep, Ed N, Klaasen, Ruth, van Laar, Jacob M, Lafeber, Floris P J G, Bijlsma, Johannes W J, de Hair, Marjolein J H, Jacobs, Johannes W G
Publicado 2020